Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 31

    1.

    Adipocyte differentiation-related protein and OXPAT in rat and human skeletal muscle: involvement in lipid accumulation and type 2 diabetes mellitus.

    Minnaard R, Schrauwen P, Schaart G, Jorgensen JA, Lenaers E, Mensink M, Hesselink MK.

    J Clin Endocrinol Metab. 2009 Oct;94(10):4077-85. Epub 2009 Jul 14.PMID: 19602560 [PubMed - indexed for MEDLINE]Related articles

    3.

    Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients.

    Phielix E, Schrauwen-Hinderling VB, Mensink M, Lenaers E, Meex R, Hoeks J, Kooi ME, Moonen-Kornips E, Sels JP, Hesselink MK, Schrauwen P.

    Diabetes. 2008 Nov;57(11):2943-9. Epub 2008 Aug 4.PMID: 18678616 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The insulin-sensitizing effect of rosiglitazone in type 2 diabetes mellitus patients does not require improved in vivo muscle mitochondrial function.

    Schrauwen-Hinderling VB, Mensink M, Hesselink MK, Sels JP, Kooi ME, Schrauwen P.

    J Clin Endocrinol Metab. 2008 Jul;93(7):2917-21. Epub 2008 May 6.PMID: 18460571 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Impact of 3-year lifestyle intervention on postprandial glucose metabolism: the SLIM study.

    Roumen C, Corpeleijn E, Feskens EJ, Mensink M, Saris WH, Blaak EE.

    Diabet Med. 2008 May;25(5):597-605.PMID: 18445174 [PubMed - indexed for MEDLINE]Related articles

    6.

    Insulin acutely upregulates protein expression of the fatty acid transporter CD36 in human skeletal muscle in vivo.

    Corpeleijn E, Pelsers MM, Soenen S, Mensink M, Bouwman FG, Kooi ME, Saris WH, Glatz JF, Blaak EE.

    J Physiol Pharmacol. 2008 Mar;59(1):77-83.PMID: 18441389 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Lifestyle intervention, glucose tolerance, and risk of developing type 2 diabetes mellitus.

    Mensink M.

    Metab Syndr Relat Disord. 2005;3(1):26-34.PMID: 18370707 [PubMed - in process]Related articles

    8.

    Type 2 diabetes mellitus and skeletal muscle metabolic function.

    Phielix E, Mensink M.

    Physiol Behav. 2008 May 23;94(2):252-8. Epub 2008 Jan 31. Review.PMID: 18342897 [PubMed - indexed for MEDLINE]Related articles

    9.

    Impaired skeletal muscle substrate oxidation in glucose-intolerant men improves after weight loss.

    Corpeleijn E, Mensink M, Kooi ME, Roekaerts PM, Saris WH, Blaak EE.

    Obesity (Silver Spring). 2008 May;16(5):1025-32. Epub 2008 Feb 28.PMID: 18309299 [PubMed - indexed for MEDLINE]Related articles

    10.

    Adipose triglyceride lipase (ATGL) expression in human skeletal muscle is type I (oxidative) fiber specific.

    Jocken JW, Smit E, Goossens GH, Essers YP, van Baak MA, Mensink M, Saris WH, Blaak EE.

    Histochem Cell Biol. 2008 Apr;129(4):535-8. Epub 2008 Jan 26.PMID: 18224330 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Lifestyle intervention and adipokine levels in subjects at high risk for type 2 diabetes: the Study on Lifestyle intervention and Impaired glucose tolerance Maastricht (SLIM).

    Corpeleijn E, Feskens EJ, Jansen EH, Mensink M, Saris WH, Blaak EE.

    Diabetes Care. 2007 Dec;30(12):3125-7. Epub 2007 Sep 21.PMID: 17890316 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Skeletal muscle uncoupling protein-3 restores upon intervention in the prediabetic and diabetic state: implications for diabetes pathogenesis?

    Mensink M, Hesselink MK, Borghouts LB, Keizer H, Moonen-Kornips E, Schaart G, Blaak EE, Schrauwen P.

    Diabetes Obes Metab. 2007 Jul;9(4):594-6.PMID: 17587402 [PubMed - indexed for MEDLINE]Related articles

    13.

    Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus.

    Mensink M, Hesselink MK, Russell AP, Schaart G, Sels JP, Schrauwen P.

    Int J Obes (Lond). 2007 Aug;31(8):1302-10. Epub 2007 Feb 20.PMID: 17310221 [PubMed - indexed for MEDLINE]Related articles

    14.

    Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects.

    Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, Jeneson JA, Backes WH, van Echteld CJ, van Engelshoven JM, Mensink M, Schrauwen P.

    Diabetologia. 2007 Jan;50(1):113-20. Epub 2006 Nov 9.PMID: 17093944 [PubMed - indexed for MEDLINE]Related articles

    15.

    Peroxisome proliferator-activated receptor-gamma coactivator-1 and insulin resistance: acute effect of fatty acids.

    Hoeks J, Hesselink MK, Russell AP, Mensink M, Saris WH, Mensink RP, Schrauwen P.

    Diabetologia. 2006 Oct;49(10):2419-26. Epub 2006 Aug 1.PMID: 16896940 [PubMed - indexed for MEDLINE]Related articles

    16.

    Improvements in glucose tolerance and insulin sensitivity after lifestyle intervention are related to changes in serum fatty acid profile and desaturase activities: the SLIM study.

    Corpeleijn E, Feskens EJ, Jansen EH, Mensink M, Saris WH, de Bruin TW, Blaak EE.

    Diabetologia. 2006 Oct;49(10):2392-401. Epub 2006 Aug 3.PMID: 16896932 [PubMed - indexed for MEDLINE]Related articles

    17.

    Reduced skeletal muscle uncoupling protein-3 content in prediabetic subjects and type 2 diabetic patients: restoration by rosiglitazone treatment.

    Schrauwen P, Mensink M, Schaart G, Moonen-Kornips E, Sels JP, Blaak EE, Russell AP, Hesselink MK.

    J Clin Endocrinol Metab. 2006 Apr;91(4):1520-5. Epub 2005 Dec 29.PMID: 16384852 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Lifestyle intervention and fatty acid metabolism in glucose-intolerant subjects.

    Mensink M, Blaak EE, Wagenmakers AJ, Saris WH.

    Obes Res. 2005 Aug;13(8):1354-62.PMID: 16129717 [PubMed - indexed for MEDLINE]Related articles

    19.

    Tobacco plants respond to the constitutive expression of the tospovirus movement protein NS(M) with a heat-reversible sealing of plasmodesmata that impairs development.

    Rinne PL, van den Boogaard R, Mensink MG, Kopperud C, Kormelink R, Goldbach R, van der Schoot C.

    Plant J. 2005 Sep;43(5):688-707.PMID: 16115066 [PubMed - indexed for MEDLINE]Related articles

    20.

    Impaired beta-adrenergically mediated lipolysis in skeletal muscle of obese subjects.

    Blaak EE, Schiffelers SL, Saris WH, Mensink M, Kooi ME.

    Diabetologia. 2004 Aug;47(8):1462-8. Epub 2004 Jul 28.PMID: 15309296 [PubMed - indexed for MEDLINE]Related articles

    21.

    Intramyocellular lipids and insulin sensitivity: does size really matter?

    Hesselink MK, Mensink M, Schrauwen P.

    Obes Res. 2004 May;12(5):741-2. No abstract available. PMID: 15166292 [PubMed - indexed for MEDLINE]Related articles

    22.

    Lifestyle intervention according to general recommendations improves glucose tolerance.

    Mensink M, Blaak EE, Corpeleijn E, Saris WH, de Bruin TW, Feskens EJ.

    Obes Res. 2003 Dec;11(12):1588-96.PMID: 14694225 [PubMed - indexed for MEDLINE]Related articles

    23.

    Human uncoupling protein-3 and obesity: an update.

    Hesselink MK, Mensink M, Schrauwen P.

    Obes Res. 2003 Dec;11(12):1429-43. Review.PMID: 14694206 [PubMed - indexed for MEDLINE]Related articles

    24.

    Lifestyle changes and lipid metabolism gene expression and protein content in skeletal muscle of subjects with impaired glucose tolerance.

    Mensink M, Blaak EE, Vidal H, De Bruin TW, Glatz JF, Saris WH.

    Diabetologia. 2003 Aug;46(8):1082-9. Epub 2003 Jul 11.PMID: 12856127 [PubMed - indexed for MEDLINE]Related articles

    25.

    Study on lifestyle-intervention and impaired glucose tolerance Maastricht (SLIM): design and screening results.

    Mensink M, Corpeleijn E, Feskens EJ, Kruijshoop M, Saris WH, de Bruin TW, Blaak EE.

    Diabetes Res Clin Pract. 2003 Jul;61(1):49-58.PMID: 12849923 [PubMed - indexed for MEDLINE]Related articles

    26.

    Subscapular skinfold thickness distinguishes between transient and persistent impaired glucose tolerance: Study on Lifestyle-Intervention and Impaired Glucose Tolerance Maastricht (SLIM).

    Mensink M, Feskens EJ, Kruijshoop M, de Bruin TW, Saris WH, Blaak EE.

    Diabet Med. 2003 Jul;20(7):552-7.PMID: 12823236 [PubMed - indexed for MEDLINE]Related articles

    27.

    Study on Lifestyle Intervention and Impaired Glucose Tolerance Maastricht (SLIM): preliminary results after one year.

    Mensink M, Feskens EJ, Saris WH, De Bruin TW, Blaak EE.

    Int J Obes Relat Metab Disord. 2003 Mar;27(3):377-84.PMID: 12629566 [PubMed - indexed for MEDLINE]Related articles

    28.

    Plasma free Fatty Acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes.

    Mensink M, Blaak EE, van Baak MA, Wagenmakers AJ, Saris WH.

    Diabetes. 2001 Nov;50(11):2548-54.PMID: 11679433 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Effect of training intensity on insulin sensitivity as evaluated by insulin tolerance test.

    Borghouts LB, Backx K, Mensink MF, Keizer HA.

    Eur J Appl Physiol Occup Physiol. 1999 Oct;80(5):461-6.PMID: 10502080 [PubMed - indexed for MEDLINE]Related articles

    30.

    In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.

    Verweij PE, Mensink M, Rijs AJ, Donnelly JP, Meis JF, Denning DW.

    J Antimicrob Chemother. 1998 Sep;42(3):389-92.PMID: 9786480 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Exogenous glucose oxidation during exercise in endurance-trained and untrained subjects.

    Jeukendrup AE, Mensink M, Saris WH, Wagenmakers AJ.

    J Appl Physiol. 1997 Mar;82(3):835-40.PMID: 9074971 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...